COVID-19 Therapeutics Available to All HRSA-supported Health Centers with Pharmacy Capacity


In December 2021, HRSA, in partnership with HHS partners, launched the HRSA Health Center COVID-19 Therapeutics Program to directly allocate a limited supply of several oral antiviral pills for the outpatient treatment of mild to moderate COVID-19 to select HRSA-supported health centers. We expanded the program earlier this month and, as of yesterday, the program is now open to all HRSA-supported health centers (including look-alikes) with pharmacy capacity. This program supports the Biden-Harris Administration’s Test to Treat Initiative.

If your health center is not yet participating, your health center’s CEO and Project Director should have received a BPHC Bulletin yesterday inviting you to join. To place an order next week, you must complete Site Selection by 11:59 p.m. your local time this Thursday, March 31.

Questions? Contact Health Center Program Support online. Under the COVID-19 category, select “View More” and select HRSA Health Center COVID-19 Therapeutics Program. You may also call 877-464-4772 from 8:00 a.m. to 8:00 p.m. ET, Monday-Friday (except federal holidays).